{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:53:39Z","timestamp":1793620419554,"version":"4.5.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Post-neurosurgical central nervous system (CNS) infection caused by multidrug-resistant (MDR)\/extensively drug-resistant (XDR) Gram-negative bacteria remains a major clinical challenge. This study describes our experience of treating such patients with combined intraventricular (IVT) and intravenous (IV) polymyxin B administration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study included six patients with post-neurosurgical CNS infections of carbapenem-resistant <jats:italic>Acinetobacter baumannii<\/jats:italic> (CRAB) or carbapenem-resistant <jats:italic>Klebsiella pneumoniae<\/jats:italic> (CRKP). All patients were treated in the intensive care unit (ICU) of First Affiliated Hospital, Zhejiang University School of Medicine (Hangzhou, China) between November 2020 and November 2021, and all received IVT plus IV polymyxin B. Data including patients' characteristics, therapeutic process, symptoms, cerebrospinal fluid (CSF) examination, laboratory tests, and complications were collected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Six patients with post-neurosurgical CNS infection were enrolled in the study. The patients comprised five males and one female, and the average age was 58 years (range, 38\u201373 years). Four out of the six cases were CRAB-positive in CSF culture, while two cases were CRKP-positive. The mean duration of polymyxin B administration was 14 \u00b1 5.69 days (range, 6\u201320 days). The average period of patients reaching CSF sterilization was 10.33 \u00b1 3.67 days (range, 5\u201314 days). All six cases were cured without acute kidney injury or epilepsy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>IVT plus IV polymyxin B is a safe and effective treatment for post-neurosurgical patients with intracranial infection caused by MDR\/XDR Gram-negative bacteria.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.913364","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:21:20Z","timestamp":1657128080000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Outcome of Using Intraventricular Plus Intravenous Polymyxin B in Post-neurosurgical Patients With Multi\/Extensively Drug-Resistant Gram-Negative Bacteria-Induced Intracranial Infection"],"prefix":"10.3389","volume":"9","author":[{"given":"Hangyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s10156-013-0608-7","article-title":"Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii","volume":"19","author":"Moon","year":"2013","journal-title":"J Infect Chemother"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1128\/AAC.00345-09","article-title":"Penetration of colistin into cerebrospinal fluid","volume":"53","author":"Markantonis","year":"2009","journal-title":"Antimicrob Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1128\/AAC.01461-12","article-title":"Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection","volume":"57","author":"Ziaka","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"2017 infectious diseases society of america's clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ijantimicag.2017.12.002","article-title":"Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii","volume":"51","author":"Chusri","year":"2018","journal-title":"Int J Antimicrob Agents."},{"key":"B6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/ene.12789","article-title":"Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis","volume":"23","author":"De Bonis","year":"2016","journal-title":"Euro J Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13756-018-0305-5","article-title":"Acinectobacter baumanniiEfficacy of intravenous plus intrathecal\/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR\/XDR : a retrospective cohort study","volume":"7","author":"Pan","year":"2018","journal-title":"Antimicrob Resist Infect Control."},{"key":"B8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/phar.2209","article-title":"International consensus guidelines for the optimal use of the polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European society of clinical microbiology and infectious diseases (ESCMID), infectious diseases society of America (IDSA), international society for anti-infective pharmacology (ISAP), society of critical care medicine (SCCM), and society of infectious diseases pharmacists (SIDP)","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy."},{"key":"B9","article-title":"Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis","volume-title":"Neurosurgery.","author":"Korinek","year":"2008"},{"key":"B10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1473-3099(09)70055-6","article-title":"Management of meningitis due to antibiotic-resistant acinetobacter species","volume":"9","author":"Kim","year":"2009","journal-title":"Lancet Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/pharmrev.120.000020","article-title":"Rescuing the last-line polymyxins: achievements and challenges","volume":"73","author":"Nang","year":"2021","journal-title":"Pharmacol Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00701-009-0382-6","article-title":"Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin","volume":"151","author":"L\u00f3pez-Alvarez","year":"2009","journal-title":"Acta Neurochir."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1086\/514754","article-title":"Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B: case report and review","volume":"28","author":"Segal-Maurer","year":"1999","journal-title":"Clin Infect Dis."},{"key":"B14","first-page":"548","article-title":"Intraventricular polymyxin B for the treatment of neonatal meningo-ventriculitis caused by multi-resistant Acinetobacter baumannii\u2013case report and review of literature","volume":"54","author":"Piparsania","year":"2012","journal-title":"Turk J Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13756-018-0313-5","volume":"7","author":"Guo","year":"2018","journal-title":"Acinetobacter baumannii successful treatment of extensively drug-resistant ventriculitis with polymyxin B and tigecycline- a case report. Antimicrob Resist Infect Control."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.2147\/IDR.S261510","article-title":"A clinical study on the use of intraventricular polymyxin B supplemented by continuous external ventricular drainage in the treatment of drug-resistant gram-negative bacilli intracranial infection","volume":"13","author":"Chen","year":"2020","journal-title":"Infect Drug Resist."},{"key":"B17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.21037\/apm-21-3149","article-title":"Efficacy and safety of intraventricular polymyxin B plus continuous ventricular drainage for the treatment of intracranial infection caused by drug-resistant Acinetobacter baumannii","volume":"11","author":"Chen","year":"2022","journal-title":"Ann Palliat Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40779-020-00253-9","article-title":"Sequential intraventricular injection of tigecycline and polymyxin B in the treatment of intracranial Acinetobacter baumannii infection after trauma: a case report and review of the literature","volume":"7","author":"Zhong","year":"2020","journal-title":"Mil Med Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"564991","DOI":"10.3389\/fped.2021.564991","article-title":"Acinetobacter baumannii successful treatment with intrathecal and intravenous polymyxin B-based combination against MDR meningitis in pediatric patient: a case report","volume":"9","author":"Xing","year":"2021","journal-title":"Front Pediatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2147\/IDR.S354460","article-title":"Acinetobacter baumannii intrathecal injection of tigecycline and polymyxin B in the treatment of extensively drug-resistant intracranial infection: a case report and review of the literature","volume":"15","author":"Li","year":"2022","journal-title":"Infect Drug Resist."},{"key":"B21","doi-asserted-by":"publisher","first-page":"106281","DOI":"10.1016\/j.ijantimicag.2021.106281","article-title":"Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration alone in intracranial infections","volume":"57","author":"Ni","year":"2021","journal-title":"Int J Antimicrob Agents."},{"key":"B22","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract."},{"key":"B23","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria","volume":"33","author":"Evans","year":"1999","journal-title":"Ann Pharmacother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/jcpt.12543","article-title":"Skin hyperpigmentation following intravenous polymyxin B treatment associated with melanocyte activation and inflammatory process","volume":"42","author":"Mattos","year":"2017","journal-title":"J Clin Pharm Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40360-018-0226-1","article-title":"Polymyxin B-induced skin hyperpigmentation: a rare case report and literature review","volume":"19","author":"Zheng","year":"2018","journal-title":"BMC Pharmacol Toxicol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e13312","DOI":"10.1111\/tid.13312","article-title":"Polymyxin B-induced skin hyperpigmentation","volume":"22","author":"Li","year":"2020","journal-title":"Transpl Infect Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ijantimicag.2016.08.010","article-title":"Histopathological findings of pigmented lesion and recovery of natural skin colour in a patient with polymyxin B-associated diffuse hyperpigmentation","volume":"48","author":"Zavascki","year":"2016","journal-title":"Int J Antimicrob Agents."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.913364\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:21:23Z","timestamp":1657128083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.913364\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":27,"alternative-id":["10.3389\/fmed.2022.913364"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.913364","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"article-number":"913364"}}